Most pre-mRNAs require an intron for efficient processing in higher eukaryotes. However, not all introns can provide this function. For example, transcripts synthesized from a variant of the human β-globin gene lacking its second intervening sequence (IVS2), yet retaining its first intervening sequence (IVS1), exhibit multiple defects in mRNA biogenesis. To investigate why, we transfected into monkey cells plasmids containing the human β-globin gene and variants of it altered in (i) IVS1, (ii) the 3′-terminal exon, and (iii) the polyadenylation signal. The β-globin RNAs accumulated in these cells were analyzed by quantitative S1 nuclease mapping for nuclear accumulation, intron excision, polyadenylation and cytoplasmic accumulation. We found that the 3′ splicing signal of IVS1, with multiple purines interrupting its polypyrimidine tract, could efficiently function as an internal 3′ splicing signal; however, it could not efficiently function as the 3′-terminal 3′ splicing signal for any of these steps in intron-dependent mRNA biogenesis unless (i) its polypyrimidine tract was made uninterrupted in pyrimidines, or (ii) specific sequences were deleted from the 3′-terminal exon. We conclude that whether an intron can provide the function necessary for efficient processing of intron-dependent pre-mRNA is dependent upon the ability of its 3′ splicing signal to define the 3′-terminal exon. On the practical side, this finding means one needs to consider both the sequence and location of the intron to be included in an intron-dependent gene to obtain efficient expression in vivo.
INTRODUCTION
The requirement of an intron for efficient processing of many pre-mRNAs has been well documented in both mammalian cells in culture (1) (2) (3) (4) (5) (6) (7) (8) and transgenic mice (9) (10) (11) . For many intron-dependent genes, the presence of introns significantly affects only post-transcriptional steps in mRNA biogenesis (2, (12) (13) (14) . These post-transcriptional effects appear to occur at numerous levels, including stabilization of the primary transcripts within the nucleus, excision of introns, polyadenylation and transport of the mature mRNAs to the cytoplasm (2, (4) (5) (6) (7) (8) (12) (13) (14) . When an intron cannot provide the function necessary for efficient pre-mRNA processing, its own excision occurs inefficiently as well (13) .
Initially, it appeared that any intron present at any location 5′ of the polyadenylation signal and within the transcribed region of the gene could provide this post-transcriptional function (2, 15) . However, more recent studies have indicated that both the location within a transcript and the sequence of the intron are important to enable efficient expression of intron-requiring genes in both tissue culture cells (8, 13, 14, 16) and transgenic mice (10) . In some cases, the intronic sequence providing this function was found to be contained, at least in part, within 30-50 bases of the 3′ splice site (4, 8, 13, 16, 17) . In another case, the sequence of the 5′ splice site was found to influence the efficiency of mRNA biogenesis (8) .
The experiments presented here were designed to identify more precisely factors that determine whether an intron can function to enable efficient processing in vivo of transcripts synthesized from an intron-dependent gene. We show that the efficiency of mRNA accumulation is affected by both (i) the sequence of the polypyrimidine tract near the 3′ splice site of the intron, and (ii) specific sequences within the 3′-terminal exon. We conclude that the efficiency with which an intron can enhance intron-dependent pre-mRNA processing correlates with the efficiency with which its 3′ splicing signal can participate in defining the 3′-terminal exon.
MATERIALS AND METHODS

Cells and transfections
The African green monkey kidney cell line CV-1PD was grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 5% fetal bovine serum as described previously (18) . Co-transfections were performed by a modification of the DEAEdextran/chloroquine procedure as described previously (12, 19) . The relative transfection efficiencies were determined by Southern blot analysis of the replicated plasmid DNA present in each sample as described previously (20) .
Recombinant plasmids
All plasmids were constructed by standard recombinant DNA techniques (21) . The construction of the starting plasmid * To whom correspondence should be addressed + Present address: Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, MA 02142, USA Figure 1 . Summary of the structures of plasmids containing alterations in the sequence of the polypyrimidine tract of human β-globin IVS1 and the data obtained with them. Only the transcribed region of each gene is shown. The remainder of each plasmid is identical in sequence and described in detail elsewhere (13) . Crosshatched boxes, human β-globin exon sequences; open boxes, human β-globin intron sequences; hatched boxes, human β-globin sequences 3′ of the polyadenylation site. The sequences within IVS1 and its variants that are directly adjacent to the 3′ splice site are shown. Bold-faced letters indicate the alterations in sequence from the wild-type intron sequence. Lower-case letters indicate purine residues located within the polypyrimidine tract. Abbreviations: A, AccI; B, BamHI; N, NcoI; R, EcoRI. The first column on the right indicates the percentage of the β-globin RNA accumulated in the nucleus plus cytoplasm of cells transfected with each plasmid from which IVS1 had been excised. These numbers were calculated from the amounts of spliced relative to spliced plus unspliced β-globin RNA detected in quantitative S1 nuclease mapping experiments similar to the one shown in Figure 2 . The numbers in the second column indicate the percentages of the β-globin RNA accumulated in the nucleus plus cytoplasm that had been cleaved at the site of polyadenylation as determined from quantitative S1 nuclease mapping experiments similar to the one shown in Figure 3 . The numbers in the third column indicate the amounts of β-globin RNA present in the cytoplasm of cells transfected with each plasmid relative to the amounts accumulated in cells transfected in parallel with pβ1(+)2(+), with normalization to the relative amounts of (i) cellular β-actin present in the same RNA samples (e.g. see Fig. 2 ), and (ii) replicated globin-encoding plasmid DNA present in the nuclear samples obtained from the same cells [determined by Southern blot analysis; data not shown]. All data are means from three experiments, the standard errors of which were at most 30% of the means unless indicated otherwise. pβ1(+)2(+), previously named pβ-βIVS(+), has been described previously (13, 22) . It contains the -812 through +2156 region (relative to the transcription initiation site) of the human β-globin gene in a pBR322-based vector that contains an SV40 origin of replication. Plasmid pβ1(-)2(-), described previously as pβ-βIVS(-) (13, 22) , is identical in sequence to pβ1(+)2(+) except for the precise lack of the two β-globin introns (Fig. 1) . The plasmid pβ1(+)2(-), lacking only the second intron, was made as described elsewhere (13) by substitution of the smaller BamHI-EcoRI fragment of pβ1(-)2(-) for the corresponding fragment from pβ1(+)2(+).
Plasmid pβ1(β2)2(-) is identical to pβ1(+)2(-) except for the substitution of the sequence 5′-AGCCTAGGCCCTTTTGCTA-ATCATGTTCATACCTCTTATCTTCCTCCCACAGGCT-3′ for nt +228 through +272 of the β-globin gene (Fig. 1) . Sequences containing the human β-globin IVS2 branch point and 3′ splice site thereby replace the wild-type IVS1 branch point and 3′ splice site. Construction of this plasmid has been described previously (23) . Plasmids pβ1(R→Y)2(-) and pβ1(R→Y′)2(-), two other IVS1 polypyrimidine tract substitution mutants of pβ1(+)2(-) (Fig. 1) , were constructed by substitution of the NcoI-AccI fragment of the human β-globin gene with PCR-generated NcoI-AccI fragments from DUP33Y5 and DUP33Y5′, respectively. These latter two plasmids, kindly provided by B. Dominski and R. Kole, contain base substitutions in the polypyrimidine tract region of IVS1 (24; Fig. 1 ).
To study the effects of sequences within the 3′-terminal exon, a series of variants of pβ1(+)2(-) was generated lacking various parts of exon III (Fig. 4) . Plasmid pβ1(+)2(-)231 was made by substitution of the BamHI-PvuII fragment of DUPY5CMV (24) , which lacks 13 nucleotides of exon II and all but 25 nucleotides of exon III just upstream of the human β-globin polyadenylation signal, for the corresponding BamHI-EcoRV region of pβ1(+)2(-)TK, a plasmid which contains an EcoRV site 3′ of the globin site of polyadenylation (16) . Plasmids pβ1(+)2(-)254, pβ1(+)2(-)289, pβ1(+)2(-)304, pβ1(+)2(-)318, pβ1(+)2(-)379, and pβ1(+)2(-)442 (Figs 4 and 9) were made by insertion into the BamHI site of pβ1(+)2(-)231 of BamHI-digested, PCR-generated fragments synthesized using pβ1(+)2(-) as template, the NcoI-containing primer described above, and 5′-GGCAGATCTAGAGCCTGAAGTTC-TCAGG-3′, 5′-GGCAGATCTAGAGATGGGCCAGCACACA-GA-3′, 5′-GCCAGATCTGAATTCTTTGCCAAAGTG-3′, 5′-TA-GGGATCCTACACTGGTGGGGTGAAT-3′, 5′-TAGGGATCCT-TAGTGATACTTGTGG-3′ and 5′-TCCGGATCCTTAGTAGTT-GGACTTAG-3′, respectively, as the second primer. To distinguish alterations in mRNA half-life in the cytoplasm from true defects in pre-mRNA processing, we also constructed a set of plasmids in which the smaller NcoI-BamHI fragment of each deleted variant was substituted with the corresponding NcoI-BamHI fragment of pβ1(R→Y)2(-).
Plasmid pβ1(+)2(-)DupE2 (Fig. 9 ) was made by insertion of a 156 bp BstYI fragment of exon II from the human β-globin gene into the BamHI site of pβ1(+)2(-)231 in the sense orientation. Plasmid pβ1(+)2(-)318AS (Fig. 9 ) was made in a similar way to pβ1(+)2(-)318, except that the PCR fragment was inserted in the anti-sense orientation.
Plasmid pRSV-Tori encodes the SV40 large T-antigen on an SV40 minimal ori + vector; its construction and structure have been described in detail elsewhere (13, 22) .
RNA purification and S1 nuclease mapping analysis
Nuclear and cytoplasmic RNAs were purified from monkey cells 48 h after transfection as described previously (12) . The primary Figure 1 . Each of the globin-encoding plasmids was co-transfected into CV-1PD cells along with the SV40 large T antigen-producing plasmid pRSV-Tori. The nuclear and cytoplasmic RNAs were purified 48 h later and analyzed by S1 nuclease mapping with the 5′ end-labeled globin-and actin-specific probes shown in (B) and (C), respectively. The bands resulting from protection with the globin and actin RNAs are indicated by arrows. The markers are MspI-cut pBR322 DNA. (B) Schematic diagram of the human β-globin probe, described previously (22) , that was used in the S1 nuclease mapping analysis shown in (A) and the DNA fragments protected by hybridization with the indicated RNAs. The human β-globin probe was 5′ end-labeled at the BamHI site; the wavy line indicates the discontinuity between the probe and the globin RNA. Abbreviations are the same as described in Figure 1 . (C) Schematic diagram of the cellular β-actin probe, described previously (22) , that was used as an internal control in the S1 nuclease mapping experiment shown in (A). The actin probe was 5′ end-labeled at the RsaI site. This probe has pBR322 sequence, indicated by wavy line, adjacent to the SalI site of the β-actin gene.
structures and relative amounts of globin RNA accumulated in nuclei and cytoplasm were determined by quantitative S1 nuclease mapping techniques as described previously (19) . The probes used in the S1 nuclease mapping analyses are shown in the figures. Cellular β-actin RNA, mapped concurrently, served as an internal control for recovery of the RNA samples and purity of the nuclear RNA (20, 22) . Hybridizations were carried out for 12 h in buffer containing 80% formamide, 0.4 M NaCl, 40 mM PIPES (pH 6.4) and 1 mM EDTA (pH 8.0) at 52 or 50_C. S1 nuclease digestions Figure 2 ; however, the probe was the 3′ end-labeled DNA shown in (B). (B) Schematic diagram of the probe used for analysis of 3′ end-cleavage for polyadenylation and the resulting fragments protected by hybridization with cleaved versus uncleaved RNA. The probe was the EcoRI fragment of pSP72βSspI, a plasmid that contains the SspI fragment of the human β-globin gene cloned into pSP72 (16) . It was 3′ end-labeled at the EcoRI site. The wavy line indicates the vector sequences adjacent to the SspI site. S, SspI. All other symbols are the same as the ones described in Figure 1 .
were performed at 25_C for 90 min. The protected DNA fragments were electrophoresed in 8 M urea, 5 or 8% polyacrylamide gels and were quantified by scanning with a PhosphorImager (Molecular Dynamics). Southern blot analyses (data not shown), performed as described elsewhere (13), of the relative amount of DpnI-resistant, β-globin-encoding plasmid DNA present in each nuclear and cytoplasmic sample prior to treatment with DNase I was used to assay for both (i) nuclear contamination of cytoplasmic nucleic acid, and (ii) differences in transfection efficiencies. The latter was found to vary at most 2-3-fold within an experiment (data not shown).
PCR reactions and DNA sequence analyses
All polymerase chain reactions were performed with a Perkin-Elmer Cetus thermal cycler. The amplification profile typically involved denaturation at 94_C for 30 s, primer annealing at 55_C for 30 s, and extension at 72_C for 2 min. DNA sequence analyses were used to confirm the structures of all plasmids; they were performed by the dideoxy chain termination method with Sequenase 2.0 (US Biochemical, Cleveland).
RESULTS
Role of polypyrimidine tract of 3′-terminal 3′ splicing signal in pre-mRNA processing
Intervening sequences are absolutely required for the expression of the human β-globin gene. In the absence of introns, transcripts The schematic diagrams on the left depict the structures of the exon III-deleted variants of the human β-globin gene. The numbers above them indicate the endpoints of the nucleotide residues deleted relative to the transcription initiation site. The size of each 3′-terminal exon is indicated in the name of the plasmid. All other symbols are the same as those described in the legend to Figure 1 . The columns on the right summarize the data obtained with these plasmids. They were determined as described in Figure 1 , except from gels similar to the ones shown in Figures 5 and 6. are synthesized at normal or near-normal levels, but fail to be properly processed or to accumulate in the cytoplasm (13,14 and references cited therein). Earlier studies by Ryu (13, 16) and Collis et al. (14) indicated, unexpectedly, that the two introns of the human β-globin gene, IVS1 and IVS2, have different effects on processing of human β-globin transcripts. Transcripts synthesized from a variant gene lacking precisely IVS2, but retaining IVS1, exhibit all of the multiple defects in pre-mRNA processing observed in the processing of transcripts made from a cDNA version of the human β-globin gene. These defects include excision of IVS1, polyadenylation, protection from rapid degradation within the nucleus, and accumulation of the mRNA in the cytoplasm. In contrast, transcripts synthesized from a variant gene lacking precisely IVS1, but retaining IVS2, are efficiently processed and accumulate to high levels in the cytoplasm.
Why is human β-globin IVS2 able to provide the function(s) needed for globin mRNA biogenesis, while human β-globin IVS1 is not? Analysis of a series of human β-globin gene mutants deleted for various parts of IVS2 had previously indicated that the IVS2-contained function mapped, at least in part, within 42 bases of its 3′ splice site (13) . To test the hypothesis that the functional difference between these two introns lay solely within the sequences at their 3′-ends, we constructed the plasmid pβ1(β2)2(-). This plasmid differs from pβ1(+)2(-), a plasmid containing an IVS2-minus variant of the human β-globin gene and an SV40 origin of replication, by substitution of the last 47 bp of IVS1 with the last 49 bp of IVS2 (Fig. 1) . These plasmids were co-transfected in parallel into monkey cells with pRSV-Tori, a plasmid encoding the SV40 large T antigen. The presence of the latter plasmid results in replication of the test plasmid to high copy number, making structural and quantitative analysis of the accumulated β-globin RNAs easy to perform by quantitative S1 nuclease mapping techniques (13, 20) . As a positive control, we also transfected in parallel the plasmid pβ1(+)2(+) which contains a genomic version of the human β-globin gene.
In confirmation of the earlier findings of Ryu (13, 16) and Collis et al. (14) , transcripts synthesized from pβ1(+)2(-) exhibited major defects in IVS1 excision (Fig. 2A, lane 4) , cleavage at the site for polyadenylation (Fig. 3A, lane 4) , protection from rapid degradation within the nucleus (Fig. 2A, lane 4) , and accumulation in the cytoplasm (Fig. 2A, lane 5 ) (see Fig. 1 for summary) . As expected, Figure 5 . Quantitative S1 nuclease mapping analysis to determine the effect on nuclear stabilization, intron excision and cytoplasmic accumulation of the β-globin RNAs accumulated in cells transfected with each of the exon III-deleted variants of the human β-globin gene depicted in Figure 4 . Shown here is an autoradiogram of the S1 nuclease-protected DNA fragments resulting from an experiment performed as described in the legend to Figure 2. transcripts synthesized from pβ1(+)2(+), containing IVS2 as well, were processed normally ( Fig. 2A, lanes 2 and 3; Fig. 3A , lanes 2 and 3). For example, the amount of β-globin RNA present in the nucleus of cells transfected with pβ1(+)2(-) was ∼1/5 of the amount present in cells transfected with pβ1(+)2(+) (Fig. 2A , lane 4 versus 2); this difference increased to w1:100 in the cytoplasm (Fig. 2A,  lane 5 versus 3) . The efficiencies of IVS1 excision and polyadenylation were estimated by measuring the steady-state levels of β-globin pre-mRNA present in the nucleus that was unspliced ( Fig. 2A) and uncleaved for 3′-end formation (Fig. 3A) , respectively, relative to the total β-globin RNA present in the nucleus plus cytoplasm of these same cells. In some cases [e.g. pβ1(+)2(-)], these measurements were probably underestimates of the real values because of rapid turnover of the pre-mRNA.
On the other hand, substitution of the sequence near the 3′ splice site of IVS1 with the corresponding one from IVS2 alleviated, in Figure 6 . Deletions in the 3′-terminal exon also affect polyadenylation. S1 nuclease mapping analysis of the 3′-ends of the β-globin RNAs accumulated in cells transfected with the exon III-deleted variants of the human β-globin gene depicted in Figure 4 . The RNA samples were the same as those used in the experiment shown in Figure 5 ; however, the probes, shown schematically below each autoradiogram, were 3′ end-labeled DNAs complementary to the corresponding primary transcripts until 50 bases past the poly(A) addition site.
large part, all four of these measured defects in processing of pβ1(+)2(-) transcripts [( Fig. 2A, lanes 6 and 7; Fig. 3A , lanes 6 and 7; summarized in Fig. 1, pβ1(β2)2(-) ]. The amount of β-globin mRNA accumulated in the cytoplasm of cells transfected with this latter plasmid is very similar to the amount accumulated in cells transfected with a plasmid containing IVS2 but lacking IVS1 (13, 14) .
To demonstrate that the 208-b S1 nuclease-protected DNA fragment observed with RNA from pβ1(β2)2(-) did, in fact, result from intron excision rather than S1 nuclease cleavage at mismatched bases, S1 nuclease mapping analysis was also performed with a probe homologous to the primary transcripts; results similar to the ones shown in Figure 2A , lanes 6 and 7 were obtained (data not shown). Therefore, the sequence necessary for efficient β-globin mRNA biogenesis which is present in IVS2 but missing from IVS1 does, indeed, map in toto within 49 bases of the 3′ splice site.
Where might the functional difference between these two 3′ splicing signal sequences lie? One plausible possibility is in the polypyrimidine tract: whereas IVS2's polypyrimidine tract is a long one, IVS1's is short and interrupted by multiple purines (Fig. 1,  lower case letters) . To test this hypothesis, we constructed the plasmids pβ1(R→Y)2(-) and pβ1(R→Y′)2(-) (Fig. 1) . These two plasmid differ from pβ1(+)2(-) solely by the substitution of the five purines within IVS1's polypyrimidine tract with complementary and non-complementary pyrimidines, respectively. These alterations in the sequence of IVS1 alleviated, in large part, the defects in all four steps in pre-mRNA processing ( Fig. 2A, lanes 8-11; Fig. 3A , lanes 8-11; summarized in Fig. 1 ). (The 220-b protected fragment present in lanes 8 and 10 in Figure 2A arose from hybrids formed with unspliced pre-mRNA that were cleaved with S1 nuclease at the discontinuities existing in the polypyrimidine region between the probe and pre-mRNA.) Noteworthy is the fact that either of these alterations in sequence from purines to pyrimidines relieved the defects. Therefore, a specific sequence is not necessary for efficient mRNA biogenesis. We conclude that the sequence required in vivo for efficient intron excision, nuclear stabilization, polyadenylation and cytoplasmic accumulation of the mRNA is simply a consensus 3′-terminal 3′ splicing signal, i.e. one containing optimal polypyrimidine tract and 3′ splice site sequences. Also noteworthy is the existence of a fairly good correlation between the ability of the 3′-terminal 3′ splicing signal to function in intron excision and its ability to enable efficient polyadenylation and cytoplasmic accumulation of the mRNA (see also below).
Effect of specific 3′-terminal exon sequences
Another plausible hypothesis as to why transcripts lacking IVS2 are defective in processing is that sequences within the adjacent exon can significantly affect the functionality of an intron when the intron's 3′ splicing signal is suboptimal (25) (26) (27) (28) . To test the effect of exon sequences on in vivo processing of human β-globin transcripts containing only IVS1, we constructed a set of plasmids, each of which differed from pβ1(+)2(-) solely by an in-frame deletion in its 3′-terminal exon (Fig. 4) . Processing of the β-globin RNAs synthesized from each of these plasmids was examined in vivo as described above (Figs 5 and 6) . Surprisingly, the transcripts synthesized from pβ1(+)2(-)231 were processed almost as efficiently as were the transcripts made from the genomic version of Figure 7 . Substitution of IVS1 by IVS1(Y), which contains a long uninterrupted polypyrimidine tract, largely rescues the defects in processing of transcripts synthesized from the exon III-deleted variants of the human β-globin gene. The schematic diagrams on the left depict the structure of the exon III-deleted variants analyzed in Figure 8 . These plasmids are identical in sequence to the corresponding ones depicted in Figure 4 except for the replacement of wild-type IVS1 by IVS1(Y), indicated by the shaded boxes. All other symbols are identical to those used in Figure 4 . The columns on the right summarize the data obtained with these plasmids from gels similar to the one shown in Figure 8 .
the human β-globin gene (Fig. 5 , lanes 4 and 5 versus 2 and 3; Fig. 6A versus Fig. 3A , lanes 2 and 3; summarized in Fig. 4) . However, other exon III-deleted variants exhibited phenotypes more similar to pβ1(+)2(-) in their efficiencies of nuclear stabilization, IVS1 excision, cleavage for polyadenylation, and cytoplasmic accumulation of globin RNA (Figs 4-6) .
The failure of the transcripts synthesized from the exon III-deleted variants pβ1(+)2(-)318, pβ1(+)2(-)379 and pβ1(+)2(-)442 to accumulate to high levels in the cytoplasm could have been a trivial consequence of the alterations in the sequence of the globin mRNAs causing their stabilities in the cytoplasm to be significantly lower than that of wild-type globin mRNA. To test this possibility, we also constructed a second set of plasmids that differed from the exon III-deleted set solely by the substitution of IVS1 with the IVS1 containing the uninterrupted polypyrimidine tract from pβ1(R→Y)2(-) (Fig. 7) . The transcripts made from this latter set of exon III-deleted variants were all processed as efficiently as were those made from pβ1(+)2(-)231 (Figs 7 and 8) . Therefore, the effect of the 3′-terminal exon sequence on the cytoplasmic accumulation of globin mRNA observed here is related to nuclear processing events, not message half-life. In addition, this effect of exon sequence is only apparent in the context of a suboptimal 3′-terminal 3′ splicing signal.
Two plausible hypotheses to explain the above finding are that the efficiency of processing is affected by (i) the size of the 3′-terminal exon, or (ii) specific sequences contained within exon III. To test the validity of hypothesis (i), we made two additional plasmids, pβ1(+)2(-)DupE2 and pβ1(+)2(-)318AS (Fig. 9) . Plasmid pβ1(+)2(-)DupE2 contains a duplication of part of exon II of the human β-globin gene. The size of the 3′-terminal exon in this construct, is thus, 387 bp. Plasmid pβ1(+)2(-)318AS is identical to pβ1(+)2(-)318 except that the exon sequence from nucleotide residues 483-495 and 1346-1414 is present in the anti-sense orientation. S1 nuclease mapping analysis indicated that these globin gene variants were significantly less defective in pre-mRNA processing than were the comparably sized exon III-deleted variants pβ1(+)2(-)379 and pβ1(+)2(-)318 (Fig. 9 versus Fig. 4; Fig. 10,  lanes 14-17 versus 12-13) . Thus, the effect of the deletions on processing is not simply a consequence of alterations in the size of the 3′-terminal exon. Rather, these data indicate that specific Figure 8 . Quantitative S1 nuclease mapping analysis of the β-globin RNAs accumulated in cells transfected with IVS1(Y)-substituted derivatives of the exon III-deleted variants of the human β-globin gene. Shown here is an autoradiogram of the S1 nuclease-protected DNA fragments resulting from an experiment performed as described in the legend to Figure 2 , except with the plasmids diagrammed in Figure 7 . The probe used in this experiment is identical to the one shown in Figure 2 ; however, in these cases, the size of the DNA fragment protected by hybridization with unspliced pre-mRNA is 220 bp because of a discontinuity between the probe and the RNA at the polypyrimidine tract near the 3′ splice site.
sequences contained within the 3′-terminal exon interfere with efficient processing when the 3′-terminal splicing signal is a suboptimal one. Furthermore, the finding of orientation dependence indicates, as expected, that these sequences probably act at the RNA level.
To further localize sequences within the 3′-terminal exon that have a major effect on the cytoplasmic accumulation of β-globin RNA, we constructed several additional variants of pβ1(+)2(-)318, this time lacking various parts of exon III between nucleotide residues 1348 and 1414 of the human β-globin gene (Fig. 9) . Deletion of nucleotide residues 1384 through 1401 led to near normal levels of intron excision and cytoplasmic accumulation of globin RNA ( Figs  9 and 10A, lanes 8-11) . Thus, sequences located, at least in part, in this region of exon III have a deleterious effect on processing of β-globin transcripts when IVS1 is the 3′-terminal intron. We conclude that specific sequences within the 3′-terminal exon can significantly interfere with pre-mRNA processing when the 3′-terminal 3′ splicing signal is a suboptimal one.
DISCUSSION
We showed here that the sequence of the polypyrimidine tract of the 3′ terminal 3′ splicing signal can significantly influence the ability of the intron to enable nuclear stabilization, intron excision, polyadenylation and cytoplasmic accumulation (Figs 1-3) . Interestingly, a fairly good correlation was found to exist between the ability of the 3′-terminal 3′ splicing signal to function in intron excision and its ability to enable each of these other steps in mRNA biogenesis to occur (Figs 1, 4, 7 and 9 ). In addition, we identified a specific sequence within the 3′-terminal exon that interferes with efficient mRNA biogenesis when the polypyrimidine tract sequence is suboptimal (Figs 4-10) . Therefore, we conclude that intron-dependent pre-mRNA processing can be strongly affected Figure 9 . Specific sequences within exon III are deleterious to processing and cytoplasmic accumulation of β-globin transcripts when IVS1 is the 3′-terminal intron. The arrows in some of the diagrams indicate the orientation of the relevant sequences. Abbreviations: BY, BstYI; all other symbols are identical to the ones used in Figure 4 . The columns on the right summarize the data obtained with these plasmids from gels similar to the one shown in Figure 10 .
by both (i) the strength or the sequence of the polypyrimidine tract of the 3′-terminal 3′ splicing signal, and (ii) specific sequences within the 3′-terminal exon.
Correlation of intron-dependent pre-mRNA processing with strength of polypyrimidine tract of 3′-terminal 3′ splicing signal
Previous work from this laboratory (13) and by Collis et al. (14) has shown that the two introns naturally present in the human β-globin gene have quite different effects on mRNA biogenesis: whereas human β-globin transcripts containing IVS2 but lacking IVS1 are processed properly and accumulate in the cytoplasm to nearly normal levels, ones containing IVS1 but lacking IVS2 are severely defective in nuclear stabilization, intron excision, polyadenylation and cytoplasm accumulation (see also Figs 1-3 ). Lang and Spritz (29) have previously shown that the presence of IVS2 can greatly enhance the efficiency of IVS1 excision in a cell-free splicing system. We found that this synergy between IVS1 and IVS2 occurs in vivo as well (Figs 1 and 2) . Thus, despite having a weak polypyrimidine tract, IVS1 can be excised efficiently when IVS2 is present 3′ of it. On the other hand, when IVS2 is translocated from its normal location to the NcoI site situated 5′ of IVS1, the human β-globin transcripts synthesized from this variant gene are severely defective in processing and cytoplasmic accumulation in vivo despite the presence of both introns (16) . Therefore, we conclude that the weak 3′ splicing signal naturally present in IVS1 of the human β-globin gene can function efficiently to define the 5′-end of a 3′-terminal exon when negative interfering sequences are lacking, but not when they are present in the 3′-terminal exon. However, this weak 3′ splicing signal can function to define the 5′-end of the internal exon II in transcripts synthesized from the genomic human β-globin gene because (i) exon II lacks a negative sequence element [Fig. 4, pβ1(+)2(-)231] , and/or (ii) the strong 5′ splice site of IVS2 present at the other end of exon II can facilitate the recognition of the weak 3′ splicing signal of IVS1 in accordance with the exon bridging model (30) .
We showed here (Figs 1 and 2 ) that the sequence difference between IVS1 and IVS2 that determines whether or not the intron can provide the function necessary for intron-dependent gene Figure 10 . Quantitative S1 nuclease mapping analysis of the β-globin RNAs accumulated in cells transfected with specific exon III-altered variants of the human β-globin gene. The experiment was performed as described in the legend to Figure 2 with the plasmids diagrammed in Figure 9 .
expression can lie solely within the polypyrimidine tract region of the 3′ splicing signal. The fact that either of two complementary changes of purines to pyrimidines led to efficient mRNA biogenesis (Fig. 1) indicates that the strength of the 3′ splicing signal, not its precise sequence, likely determines whether an intron can function to enable efficient mRNA biogenesis. Although the polypyrimidine tract of the 3′ splicing signal of IVS2 may be only slightly better than IVS1's, it functions as a stronger splicing signal because of a better branch point sequence (32) . Here, we increased the overall strength of IVS1's 3′ splicing signal by creating a better polypyrimidine tract, instead.
An alternative hypothesis consistent with our findings is that IVS1's 3′ splicing signal fails to be efficiently recognized because it interacts, instead, with the negative element identified here within exon III that is contained, at least in part, within nucleotides 1383-1401 (5′-CACTTTGGCAAAGAATTCA-3′). Although additional experiments are necessary to test this hypothesis, we consider it less likely because of the good correlation found between the strength of the 3′ splicing signal and the efficiency of mRNA biogenesis.
Our conclusion that a weak 3′ splicing signal cannot always function efficiently in mRNA biogenesis provides an explanation for some previously not understood findings: (i) the human β-globin gene is not expressed efficiently when its IVS2 is replaced with the IVS2 of the human δ-globin gene (31) which also contains a suboptimal polypyrimidine tract; and (ii) the 3′ splicing signal of the immunoglobulin G intron, which contains a long uninterrupted polypyrimidine tract, works better than the 3′ splicing signal of the SV40 small t-antigen intron to enable efficient expression of genes in transgenic mice (11) . Thus, we conclude that one should include as the 3′-terminal intron an intron with an optimal 3′ splicing signal to obtain efficient processing and cytoplasmic accumulation of mRNAs synthesized from intron-dependent genes.
Function of introns in intron-dependent gene expression
Although the precise mechanism underlying the requirement for introns remains unknown, much evidence suggests that the presence of introns enhances gene expression through a posttranscriptional mechanism(s), probably at the levels of RNA stabilization, processing and transport (2, 4, 5, 7, 8, 12) . Our findings that the efficiency of mRNA biogenesis can be affected by both (i) the length and/or strength of the polypyrimidine tract of the 3′ splicing signal (Fig. 1) , and (ii) a 3′-terminal exon sequence in the sense, but not anti-sense orientation (Figs 9 and 10 ), provide additional strong support for the mechanism being posttranscriptional in nature.
Several lines of evidence indicate that recognition of the 3′-terminal 3′ splicing signal and polyadenylation signal are coupled. First, the presence of introns has been clearly shown to affect 3′-end formation in vivo. Both Collis et al. (14) and we ( Figs 3A and 6 ) have observed that cells transfected with some intron-altered variants of the human β-globin gene accumulate unpolyadenylated pre-mRNAs to abnormally high levels. Others have made similar observations with other genes deleted in their 3′-terminal 3′ splice site (7, 17, 33, 34) . Although histone transcripts are not normally polyadenylated, insertion of an intron results in their becoming polyadenylated (35) . Second, Berget and colleagues have elegantly demonstrated using a cell-free RNA processing system a direct interaction between a 3′ splicing signal and a polyadenylation signal (36, 37) . They showed that polyadenylation is stimulated in vitro by placement of a 3′ splicing signal 5′ of the polyadenylation signal, with mutation of the polyadenylation signal depressing splicing of the proximal intron and vice versa. Third, we have previously demonstrated that polyadenylation site selection cannot occur in vivo after excision of the 3′-terminal intron (19) . Fourth, we showed here (Figs 1 and 4) and elsewhere (23) that a fairly good correlation exists between the strength of the 3′-terminal 3′ splicing signal as measured by intron excision and the efficiency of cleavage for polyadenylation. These latter data provide strong additional in vivo support for the concept that 3′-terminal exons are defined by interactions between the splicing and polyadenylation machineries. Thus, one function of an intron in intron-dependent gene expression is probably to enable definition of the 3′-terminal exon and, subsequently, to facilitate polyadenylation by mechanisms similar to ones proposed previously (e.g. ref. 19) .
The polypyrimidine tract is recognized at a very early step in splicing (38) (39) (40) . Its precise sequence, polypyrimidine content, length, location and context are important determinants of its function (24, (39) (40) (41) (42) (43) . Several factors have been shown to bind selectively to the polypyrimidine tract. These factors include U2AF (44, 45) , intron-binding protein (46, 47) , polypyrimidine-tract binding protein (pTB) (48, 49) and heterogeneous nuclear RNP proteins (43, 50) . Furthermore, proteins associated with the polypyrimidine tract can exchange during the course of the splicing reaction (51, 52) . However, the precise functions of these proteins in pre-mRNA processing remain unclear. We speculate that the presence of a good polypyrimidine tract in the 3′-terminal 3′ splicing signal increases the efficiency of a very early step in pre-mRNA processing, probably the definition of the 3′-terminal exon.
A non-mutually exclusive, alternative hypothesis to explain the effect of introns on RNA processing is that the presence of introns enhances the initial stabilization of primary transcripts within the nucleus. For example, we have shown recently that transcripts synthesized from the naturally intronless herpes simplex virus thymidine kinase gene contain a cis-acting RNA sequence element that enables efficient intron-independent processing and cytoplasmic accumulation of human β-globin transcripts (20) . This RNA element functions by binding hnRNP L. Possibly, intron-dependent genes contain functionally comparable elements only within or at the splicing signals of their introns. Thus, the assembly of spliceosomes on intron-containing pre-mRNAs would lead to initial stabilization within the nucleus. Following removal of all of the introns along with their bound proteins, the fully processed mRNA could be transported to the cytoplasm (53, 54) . However, transcripts containing an intron that fails to be excised efficiently [e.g. ones from pβ1(+)2(-) in Figs 1 and 2 ] would be retained in the nucleus and degraded.
Effects of specific sequences within the 3′-terminal exon
Human β-globin transcripts have long served as a model system for studying pre-mRNA processing, with IVS1 being excised quite efficiently under appropriate cell-free conditions (55) . Fortuitously, the substrate used in most of these studies was truncated at the BamHI site within exon II. When the substrate contains exon III as well, excision of IVS1 occurs very inefficiently (29) . Our in vivo data are consistent with these in vitro observations: whereas, IVS1 is excised efficiently in cells transfected with pβ1(+)2(-)231, it is excised inefficiently in cells transfected with pβ1(+)2(-) (Figs 1, 2, 4 and 5). Furthermore, we went on to identify a specific sequence within exon III that can cause excision of IVS1 to occur inefficiently. The sequence is contained, at least in part, between nucleotides 1383 and 1401. It is not yet clear whether this sequence operates by itself or does so in conjunction with other sequences. Nor is its mode of action apparent. However, we do know that the inhibitory effect of this exon sequence on pre-mRNA processing occurs only when the 3′-terminal 3′ splicing signal is suboptimal since the presence of a pyrimidine-rich polypyrimidine tract can overcome its influence (Fig. 9) .
The inhibitory 3′-terminal exon sequence affects all steps in pre-mRNA processing measured here (Figs 4-6) . Thus, we speculate that it probably acts by interfering with the definition of the 3′-terminal exon. Previous studies by others have shown that the presence within a 3′-terminal exon of a sequence similar to a 5′ splice site can lead to significant reduction in the accumulation of an mRNA (56) (57) (58) . Likewise, Furdon and Kole (59) found that polypyrimidine-rich sequences are 'poisonous' to splicing in vitro when placed within the 3′-terminal exon. Negative sequence elements that affect splicing of weak introns in retroviruses have also been identified (26, 28) . Close visual examination of the sequence we identified in exon III of the human β-globin gene revealed no obvious similarity to these previously identified inhibitory elements. Our finding that this globin-contained inhibitory element functions in an orientation-dependent manner (Figs 9 and 10) suggests that it probably acts at the RNA level. It will be of interest to determine whether this element functions in a context-or position-dependent manner.
Contrary to our results, Buchman and Berg (4) found that inclusion of either intron in variants of the rabbit β-globin gene enabled efficient processing. In a first attempt to account for this discrepancy, we substituted IVS1 from the rabbit β-globin gene for IVS1 of the human β-globin gene in pβ1(+)2(-); human β-globin mRNA still failed to accumulate in the cytoplasm (60) . Substitution of the strong SV40 late polyadenylation signal by Buchman and Berg for the relatively weak globin polyadenylation signal used by us also failed to rescue the defect in processing of IVS1(+)IVS2(-) human β-globin transcripts (23; data not shown). Thus, we conclude that differences in specific sequences within exon III of human β-globin versus rabbit β-globin, possibly the inhibitory one identified here, most likely account for this observed discrepancy in the findings of our two laboratories. However, additional experiments are needed to test the validity of this hypothesis.
In summary, we showed here that the sequence of the polypyrimidine tract of the 3′-terminal 3′ splicing signal can affect multiple steps in pre-mRNA processing including nuclear stabilization, splicing, polyadenylation and cytoplasmic accumulation. When the 3′ splicing signal is suboptimal, specific exon sequences can also affect pre-mRNA processing. These data provide explanations for why some introns can enhance gene expression, while others fail to do so. In addition, they indicate that one may achieve increased expression of intron-dependent genes by inclusion of an intron with an optimal 3′ splicing signal as the 3′-terminal intron in the transcription unit.
